Markets » Mutual Funds » Asset Allocation

Nippon India Pharma Fund - Direct (D) - Scheme Profile

Fund

Fund House : Nippon India Mutual Fund

Fund Class : Equity - Pharma

NAV 07 Jul 2020 75.44 0.04
(0.05%)

Asset Type

Asset Allocation
Cash & Cash Equivalent 0.00
Derivatives 0.05
Equity 99.11
Reverse Repo 2.67
Equity Sector No. of Shares Mkt Value % of Assets Stocks Return
Asset / Company Name     (Rs cr)   Last 3 Mths
Aurobindo Pharma Pharmaceuticals - Indian - Bulk Drugs & Fo... 4,800,000 357.91 11.96 82.99
Cipla Pharmaceuticals - Indian - Bulk Drugs & Fo... 4,800,000 311.11 10.40 23.67
Dr Reddy's Labs Pharmaceuticals - Indian - Bulk Drugs & Fo... 745,000 303.31 10.14 5.58
Sun Pharma.Inds. Pharmaceuticals - Indian - Bulk Drugs & Fo... 6,300,976 298.82 9.99 10.84
Divi's Lab. Pharmaceuticals - Indian - Bulk Drugs 1,100,075 262.93 8.79 -0.1
Lupin Pharmaceuticals - Indian - Bulk Drugs 2,800,025 243.55 8.14 22.68
› More

Sector Allocation

You can check out the sectoral allocation of the investments made for that scheme by the mutual fund in this Piechart as on the date selected.

Sector Name
Healthcare 11.48
NA 2.72
Pharmaceuticals - Indian - Bulk Drugs 16.93
Pharmaceuticals - Indian - Bulk Drugs & Formln 61.63
Pharmaceuticals - Indian - Formulations 0.63
Pharmaceuticals - Multinational 8.44

Top Holdings

You can check out the Top Holdings of the investments made for that scheme by the mutual fund in
this Piechart as on the date selected.

Company Name
Abbott India 3.92
Alkem Lab 2.35
Aurobindo Pharma 11.96
Biocon 4.75
Cadila Health. 4.02
Cipla 10.40
Divi's Lab. 8.79
Dr Reddy's Labs 10.14